Electrocore vs Utah Medical Products
Utah Medical Products is the larger business, with $38.5m of revenue in fiscal 2025 against $32.0m for Electrocore (1.2 times as much). Electrocore grew faster (27.2% against -5.8%). Utah Medical Products kept more of each dollar of sales as profit: a net margin of 29.3% against -43.6%.
| Latest fiscal year | ElectrocoreECOR, 2025 | Utah Medical ProductsUTMD, 2025 |
|---|---|---|
| Revenue | $32.0m | $38.5m |
| Revenue growth | 27.2% | -5.8% |
| Net income | −$14.0m | $11.3m |
| Operating margin | -41.1% | 29.6% |
| Net margin | -43.6% | 29.3% |
| Return on equity | — | 9.5% |
| Free cash flow | −$8.3m | $14.3m |
| Cash | $7.0m | $85.8m |
| Total debt | $7.8m | $225,000 |
| Debt to equity | — | 0.2% |
| Dividend per share | — | — |
| Dividend yield | — | 1.8% |
| Share buybacks | — | $8.4m |
| Employees | 83 | 140 |
| Market value | $64.3m | $223m |
| Price vs our value range | — | Below our value range |
| Moat score | 37 (Weak) | 100 (Strong) |
| Insider trades, 12 months | 5 buys, 9 sales | 0 buys, 0 sales |